止血材の世界市場レポート 2025年

止血材の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.8％で46億7,000万米ドルに成長します。予測期間の成長は、緊急事態への備えとパンデミック対応、世界のヘルスケアインフラ開発、低侵襲手術の需要拡大、様々な専門分野での用途拡大、生体適合性の重視などに起因すると考えられます。予測期間における主な動向としては、製品のイノベーション、止血技術の進歩、低侵襲手術への注目などが挙げられます。

外科手術の増加は、止血材市場の今後の成長を促進すると予想されます。外科的処置とは、病理学的状態を検査または治療するために人に使用されるあらゆる形態の侵襲的治療を指します。止血材は、手術中の出血を防ぐために使用されるため、外科処置には不可欠です。例えば、2023年9月、レバノンを拠点とする形成外科専門医の専門組織である国際美容形成外科学会によると、2022年に形成外科医によって行われた手術は全体で11.2％増加し、世界中で1,490万件以上の外科手術と1,880万件以上の非外科手術が行われました。さらに、外科手術と非外科手術の両方が、前回の調査から増加しています（それぞれ16.7％と7.2％）。したがって、外科手術の増加が止血材市場の成長を牽引しています。

止血材市場は、無料手術を提供することを目的とした政府の取り組みによって、さらなる成長が見込まれています。患者に料金を請求せずに行われる無料手術は、経済的に恵まれない人々の治療負担を軽減します。PubMedの2022年5月の記事で報告されているように、インド全土の三次医療病院で実施された調査で、大きな影響があることが明らかになりました。回答者の約41.7％が腹腔鏡手術と開腹手術の両方を等しく行っており、止血材の多様な応用が実証されました。手術需要の急増、特に止血材の使用動向は、止血材市場の成長促進における政府の取り組みの極めて重要な役割を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の止血材市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の止血材市場：成長率分析
• 世界の止血材市場の実績：規模と成長、2019～2024年
• 世界の止血材市場の予測：規模と成長、2024～2029年、2034年
• 世界の止血材総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の止血材市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• トロンビンベース止血材
• 酸化再生セルロースベース止血材
• 複合止血材
• ゼラチン系止血材
• コラーゲン系止血材
• 世界の止血材市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• アクティブ止血材
• パッシブ止血材
• 複合止血材
• その他の製品
• 世界の止血材市場：処方別、実績と予測、2019～2024年、2024～2029年、2034年
• マトリックスおよびジェル止血材
• シートおよびパッド止血材
• スポンジ止血材
• パウダー止血剤
• 世界の止血材市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 整形外科
• 一般外科
• 神経外科
• 心臓血管外科
• 再建手術
• 婦人科手術
• その他の用途
• 世界の止血材市場：トロンビンベース止血剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所トロンビン
• 凍結乾燥トロンビン
• 世界の止血材市場：酸化再生セルロース系止血材のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• パッド
• 顆粒
• 世界の止血材市場：複合止血剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• トロンビン・ゼラチン複合
• トロンビン・コラーゲン複合
• 世界の止血材市場：ゼラチン系止血材のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ジェルフォーム
• ゼラチンスポンジ
• 世界の止血材市場：コラーゲン系止血材のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コラーゲンシート
• コラーゲンパウダー

第7章 地域別・国別分析

• 世界の止血材市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の止血材市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 止血材市場：競合情勢
• 止血材市場：企業プロファイル
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic PLC
• Hemostasis LLC
• Stryker Corporation
• Advanced Medical Solutions Group PLC
• Samyang Holdings Corporation
• Gelita Medical GmbH
• CryoLife Inc.
• CuraMedical B.V.
• Meril Life Sciences Pvt. Ltd.
• Beijing Datsing Bio-Tech Co. Ltd.
• Zhonghui Shengxi（Beijing）Medical Technology Co. Ltd.
• Biotemed Inc.
• Biom'up SA
• Shandong Foryou Medical Devices Co. Ltd.
• Z-Medica LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 止血材市場2029年：新たな機会を提供する国
• 止血材市場2029年：新たな機会を提供するセグメント
• 止血材市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A hemostat is a surgical tool employed in various surgical procedures to control or compress bleeding vessels, facilitating the treatment of wounds and aiding in visualizing deeper regions during surgeries.

There are several types of hemostats, including thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Thrombin-based hemostats are used to control and reduce blood loss during surgical procedures, either in conjunction with or as an alternative to traditional surgical techniques. Thrombin is an enzyme that breaks down fibrinogen into fibrin, promoting blood clotting. Examples of active hemostats include topical (bovine) thrombin (Thrombin-JMI), topical (human) thrombin (Evithrom), and topical (recombinant) thrombin (Recothrom). They are available in various forms, such as active hemostats, passive hemostats, combination hemostats, and others. Formulations include matrix and gel hemostats, sheet and pad hemostats, sponge hemostats, and powder hemostats. These hemostats find applications in orthopedic surgery, general surgery, neurological surgery, cardiovascular surgery, reconstructive surgery, gynecological surgery, and other medical procedures.

The hemostats market research report is one of a series of new reports from The Business Research Company that provides hemostats market statistics, including hemostats industry global market size, regional shares, competitors with a hemostats market share, detailed hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats industry. This hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats market size has grown strongly in recent years. It will grow from $3.37 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications.

The hemostats market size is expected to see strong growth in the next few years. It will grow to $4.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emergency preparedness and pandemic response, global healthcare infrastructure development, growing demand for minimally invasive surgeries, expanding applications in various specialties, focus on biocompatibility. Major trends in the forecast period include product innovations, advancements in hemostatic technologies, focus on minimally invasive surgeries.

An increase in surgical procedures is expected to propel the growth of the hemostat market going forward. Surgical procedures refer to all forms of invasive treatments that are used on a person to investigate or treat a pathological condition. Hemostats are essential for surgical procedures as they are used to prevent blood loss while performing surgery. For instance, in September 2023, according to the International Society of Aesthetic Plastic Surgery, a Lebanon-based professional organization for board-certified plastic surgeons, there was an 11.2% overall increase in procedures performed by plastic surgeons in 2022, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide. Additionally, both surgical and non-surgical procedures showed increases since the last survey (16.7% and 7.2% respectively). Therefore, an increase in surgical procedures is driving the growth of the hemostat market.

The hemostat market is poised for further growth, driven by government initiatives aimed at providing free surgeries. Free surgeries, performed without charging patients, alleviate the treatment burden on the economically disadvantaged. A survey conducted in tertiary care hospitals across India, as reported in a May 2022 article on PubMed, revealed a significant impact. Approximately 41.7% of respondents performed both laparoscopic and open procedures equally, demonstrating the diverse application of hemostats. The surge in surgical demand, especially with the trend toward hemostat usage, emphasizes the pivotal role of government initiatives in propelling the hemostat market's growth.

Technological advancement emerges as a key trend shaping the hemostat market, with major companies investing in new technologies and research and development efforts. Baxter, a prominent US-based healthcare company, exemplifies this trend through the launch of PERCLOT Absorbable Hemostatic Powder in March 2022. This passive, absorbable hemostatic powder is designed for patients with intact coagulation to address mild bleeding, providing surgeons with a versatile tool for bleeding control. The emphasis on technological innovation highlights the commitment to optimizing patient care and expanding the range of hemostatic solutions.

Major companies in the hemostat market are strategically engaging in partnerships and collaborations, particularly with start-ups and mid-sized companies, to enhance their product and service offerings. In May 2023, Olympus, a Japan-based manufacturer of optics and reprography products, expanded its partnership with Endoclot, a US-based medical device company. This collaboration aims to launch hemostatic agents, contributing to safe treatment in gastrointestinal procedures. By entering strategic partnerships, companies like Olympus seek to broaden their product portfolios and geographical reach, ultimately elevating the standard of care and improving patient outcomes in the hemostat market.

In December 2022, Integra LifeSciences, a US-based medical technology company, acquired Surgical Innovation Associates for $150 million. This acquisition allows Integra LifeSciences Holding Corporation to enhance its product portfolio, expand its market reach, and strengthen its position in the medical technology sector. Surgical Innovation Associates is a US-based company specializing in providing advanced surgical technologies and solutions.

Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton Dickinson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostat market consists of sales of cellulose based and thrombin-based hemostats. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Thrombin-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Combination Hemostats; Gelatin-Based Hemostats; Collagen-Based Hemostats
• 2) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
• 3) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats
• 4) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
• Subsegments:
• 1) By Thrombin-Based Hemostats: Topical Thrombin; Lyophilized Thrombin
• 2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads; Granules
• 3) By Combination Hemostats: Thrombin And Gelatin Combinations; Thrombin And Collagen Combinations
• 4) By Gelatin-Based Hemostats: Gelfoam; Gelatin Sponge
• 5) By Collagen-Based Hemostats: Collagen Sheets; Collagen Powder
• Companies Mentioned: B. Braun Melsungen AG; Baxter International Inc.; Integra LifeSciences Corporation; Becton Dickinson and Company; Teleflex Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostats Market Characteristics

3. Hemostats Market Trends And Strategies

4. Hemostats Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hemostats Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hemostats PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hemostats Market Growth Rate Analysis
• 5.4. Global Hemostats Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hemostats Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hemostats Total Addressable Market (TAM)

6. Hemostats Market Segmentation

• 6.1. Global Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombin-Based Hemostats
• Oxidized Regenerated Cellulose-Based Hemostats
• Combination Hemostats
• Gelatin-Based Hemostats
• Collagen-Based Hemostats
• 6.2. Global Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Active Hemostats
• Passive Hemostats
• Combination Hemostats
• Other Product
• 6.3. Global Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Matrix And Gel Hemostats
• Sheet And Pad Hemostats
• Sponge Hemostats
• Powder Hemostats
• 6.4. Global Hemostats Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Other Applications
• 6.5. Global Hemostats Market, Sub-Segmentation Of Thrombin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Thrombin
• Lyophilized Thrombin
• 6.6. Global Hemostats Market, Sub-Segmentation Of Oxidized Regenerated Cellulose-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pads
• Granules
• 6.7. Global Hemostats Market, Sub-Segmentation Of Combination Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thrombin And Gelatin Combinations
• Thrombin And Collagen Combinations
• 6.8. Global Hemostats Market, Sub-Segmentation Of Gelatin-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gelfoam
• Gelatin Sponge
• 6.9. Global Hemostats Market, Sub-Segmentation Of Collagen-Based Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Collagen Sheets
• Collagen Powder

7. Hemostats Market Regional And Country Analysis

• 7.1. Global Hemostats Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hemostats Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostats Market

• 8.1. Asia-Pacific Hemostats Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostats Market

• 9.1. China Hemostats Market Overview
• 9.2. China Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostats Market

• 10.1. India Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostats Market

• 11.1. Japan Hemostats Market Overview
• 11.2. Japan Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostats Market

• 12.1. Australia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostats Market

• 13.1. Indonesia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostats Market

• 14.1. South Korea Hemostats Market Overview
• 14.2. South Korea Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostats Market

• 15.1. Western Europe Hemostats Market Overview
• 15.2. Western Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostats Market

• 16.1. UK Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostats Market

• 17.1. Germany Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostats Market

• 18.1. France Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostats Market

• 19.1. Italy Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostats Market

• 20.1. Spain Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostats Market

• 21.1. Eastern Europe Hemostats Market Overview
• 21.2. Eastern Europe Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostats Market

• 22.1. Russia Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostats Market

• 23.1. North America Hemostats Market Overview
• 23.2. North America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostats Market

• 24.1. USA Hemostats Market Overview
• 24.2. USA Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostats Market

• 25.1. Canada Hemostats Market Overview
• 25.2. Canada Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostats Market

• 26.1. South America Hemostats Market Overview
• 26.2. South America Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostats Market

• 27.1. Brazil Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostats Market

• 28.1. Middle East Hemostats Market Overview
• 28.2. Middle East Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostats Market

• 29.1. Africa Hemostats Market Overview
• 29.2. Africa Hemostats Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hemostats Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hemostats Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostats Market Competitive Landscape And Company Profiles

• 30.1. Hemostats Market Competitive Landscape
• 30.2. Hemostats Market Company Profiles
  • 30.2.1. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Hemostats Market Other Major And Innovative Companies

• 31.1. Medtronic PLC
• 31.2. Hemostasis LLC
• 31.3. Stryker Corporation
• 31.4. Advanced Medical Solutions Group PLC
• 31.5. Samyang Holdings Corporation
• 31.6. Gelita Medical GmbH
• 31.7. CryoLife Inc.
• 31.8. CuraMedical B.V.
• 31.9. Meril Life Sciences Pvt. Ltd.
• 31.10. Beijing Datsing Bio-Tech Co. Ltd.
• 31.11. Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd.
• 31.12. Biotemed Inc.
• 31.13. Biom'up SA
• 31.14. Shandong Foryou Medical Devices Co. Ltd.
• 31.15. Z-Medica LLC

32. Global Hemostats Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats Market

34. Recent Developments In The Hemostats Market

35. Hemostats Market High Potential Countries, Segments and Strategies

• 35.1 Hemostats Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hemostats Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hemostats Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer